Lisa Charter

Lisa Charter serves as Vice President of Regulatory Affairs at Alveo Technologies, where she brings more than 20 years of experience in regulatory affairs, quality assurance, and research and development in the areas of therapeutic drug monitoring, toxicology, anatomical pathology, hematology, allergy diagnostics, and direct-to-consumer genetics. A veteran medical device professional, Lisa joined Alveo from Atonarp, where she served in a similar capacity. Prior to Atonarp, Lisa led regulatory efforts at 23andMe to secure several first of their kind de novo authorizations and 510(k) clearances for direct-to-consumer genetic tests. Before 23andMe, Lisa held similar roles at Hitachi Chemical Diagnostics and ThermoFisher Scientific.